Decreased Expression of Insulin-like Growth Factor-1 and Apoptosis of Vascular Smooth Muscle Cells in Human Atherosclerotic Plaque
Overview
Authors
Affiliations
Insulin-like growth factor-1 (IGF-1) plays an important role in migration, cell cycle progression and survival of vascular smooth muscle cells (VSMC). We investigated the specific localization of IGF-1 and its receptor (IGF-1R) and their association with apoptosis and the expression of apoptosis-related proteins in early and advanced atherosclerotic lesions. Human atherosclerotic plaques (n=23) from patients undergoing aortic, carotid or femoral arterial surgery were studied. Immunohistochemistry and in situ hybridization revealed significantly higher expression of IGF-1 and IGF-1R in the media than in the intima of early atherosclerotic lesions (P<0.01). Medial VSMC positive for BAX, a proapoptotic protein of the B-cell CLL/lymphoma 2 (BCL2) family, showed colocalization of IGF-1. Apoptosis, as detected by DNA in situ terminal deoxynucleotidyl transferase end labeling (TUNEL), was not present in these early lesions. In advanced atherosclerotic plaques, the expression of IGF-1 and IGF-1R was significantly lower in the intimal regions with macrophage infiltration than in those without macrophage infiltration or than in the media (P<0.01). Furthermore, IGF-1 and IGF-1R immunoreactivity was markedly lower in intimal TUNEL-positive VSMC compared with intimal BAX-positive and medial VSMC (P<0.01). We conclude that IGF-1 and IGF-1R expression are reduced in the deep intima of early atherosclerotic lesions and in areas of advanced plaques with macrophage infiltration. Since IGF-1 is a potent survival factor for VSMC, poor expression of IGF-1 and IGF-1R in intimal regions with macrophage infiltration would likely contribute to triggering VSMC apoptosis potentially leading to plaque weakening, plaque rupture and acute coronary events.
Sukhanov S, Higashi Y, Yoshida T, Danchuk S, Alfortish M, Goodchild T JCI Insight. 2023; 8(4).
PMID: 36602878 PMC: 9990768. DOI: 10.1172/jci.insight.165713.
Li T, Zhao Y, Yang X, Feng Y, Li Y, Wu Y J Endocrinol Invest. 2022; 45(12):2221-2231.
PMID: 35596917 DOI: 10.1007/s40618-022-01819-1.
Vascular dysfunction as a potential culprit of sarcopenia.
Jeon Y, Shin M, Saini S, Custodero C, Aggarwal M, Anton S Exp Gerontol. 2020; 145:111220.
PMID: 33373710 PMC: 8168450. DOI: 10.1016/j.exger.2020.111220.
Li Y, Wu X, Gao F, Wang X Int J Clin Exp Pathol. 2020; 12(11):4181-4192.
PMID: 31933818 PMC: 6949791.
Norling A, Gerstenecker A, Buford T, Khan B, Oparil S, Lazar R Geroscience. 2019; 42(1):141-158.
PMID: 31808026 PMC: 7031491. DOI: 10.1007/s11357-019-00139-2.